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Abstract
Association studies using tag SNPs have been successful in detecting disease-associated common variants. However,
common variants, with rare exceptions, explain only at most 5–10% of the heritability resulting from genetic factors,
which leads to the common disease/rare variants assumption. Indeed, recent studies using sequencing technologies
have demonstrated that common diseases can be due to rare variants that could not be systematically studied earlier.
Unfortunately, methods for common variants are not optimal if applied to rare variants. To identify rare variants that
affect disease risk, several investigators have designed new approaches based on the idea of collapsing different rare
variants inside the same genomic block (e.g., the same gene or pathway) to enrich the signal. Here, we consider three
different collapsing methods in the multimarker regression model and compared their performance on the Genetic
Analysis Workshop 17 data using the consistency of results across different simulations and the cross-validation
prediction error rate. The comparison shows that the proportion collapsing method seems to outperform the other two
methods and can find both truly associated rare and common variants. Moreover, we explore one way of incorporating
the functional annotations for the variants in the data that collapses nonsynonymous and synonymous variants
separately to allow for different penalties on them. The incorporation of functional annotations led to higher sensitivity
and specificity levels when the detection results were compared with the answer sheet. The initial analysis was
performed without knowledge of the simulating model.
Background
Genome-wide association studies (GWAS) have success-
fully identified thousands of common variants associated
with the risk of common diseases [1,2]. To date, GWAS
have been mostly conducted under the common disease/
common variants (CDCV) hypothesis, which asserts that
common diseases are mostly caused by common variants
with small to modest effects [3-6]. Typically, only variants
with a minor allele frequency (MAF) greater than 1–5%
are considered in these studies. However, despite the
identification of thousands of common variants that
affect common disease risk, with rare exceptions these
common variants can explain at most 5–10% of the
heritable component of disease [7]. Theoretical studies
based on evolutionary theories suggest that less common
variations are more likely to be functional than common
variations [8,9]. Recent studies using sequencing technol-
o g yh a v ea l s od e t e c t e dm a n yr a r ev a r i a n t st h a ta r ea s s o -
ciated with disease [7], providing empirical evidence for
the common disease/rare variant (CDRV) hypothesis. All
these studies suggest that the complex disease etiology
can be a mixture of common variants and rare variants.
Typical GWAS detect disease-associated variants using
indirect linkage disequilibrium (LD) mapping, which cap-
tures the information of correlated single-nucleotide poly-
morphisms (SNPs) using a set of tag SNPs to reduce the
number of testing. However, this strategy is not efficient
when applied to rare variants because the correlation
between the rare variants and the tag SNPs is often weak
as a result of the low MAF of the rare variants. Alternative
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offer some advantages over the traditional LD mapping
[10]. In addition, direct mapping through exhaustive geno-
typing or sequencing is more appropriate for identifying
functional rare variants.
To analyze the sequencing data, many investigators have
developed association tests to detect disease-associated rare
variants. These tests fall into three main types: (1) multiple
univariate single-marker tests, (2) multiple-marker tests,
and (3) collapsing methods. The univariate single-marker
tests assess the significance of association for every rare
variant independently. The multiple-marker tests instead
test for the association of a set of variants simultaneously
[11]. Both single-marker and multiple-marker tests have
reduced power because of the multiple testing correction.
In addition, the power of single-marker tests for low-fre-
quency variants is sensitive to the effect size [12]. The col-
lapsing methods combine information across multiple
variants in the same genomic block (e.g., the same gene or
pathway) so that the association signals can be enriched
and the test’s degrees of freedom can be reduced [11-14].
Here, we consider three different collapsing methods for
rare variants in the same gene. Regression with a LASSO
(least absolute shrinkage and selection operator) penalty is
then used to choose the significant collapsed rare variants
or common variants. The three collapsing methods are
compared based on the consistency across replicates, the
cross-validation error rate of the fitted model, and the list
of true causal variants. The most significant common var-
iants and collapsed rare variants are shown. We also
explore the incorporation of the functional annotation
information of all the variants in the regression model. By
comparing the results with the list of true causal variants,
we find that incorporation of the functional annotation
leads to higher sensitivity and specificity levels.
Methods
Collapsing rare variants
All the variants are divided into two groups. Variants
with MAF > 5% fall into the common variants group, and
all the other variants form the rare variants group. Note
that this definition of rare variants is specific to this
paper. We also considered a more common definition of
rare variants with MAF ≤ 1% and came to the same con-
clusions (results not shown). The rare variants in the
same gene are collapsed using the proportion coding
(PROP), the data-adaptive sum (DAS), and the weighted-
sum (WS) methods. Details and assumptions of these
collapsing methods can be found in Dering et al. [15].
Multiple regression model
We used a multiple regression model to assess the associa-
tion of variants with the phenotype after the collapsing.
Suppose that in individual i the collapsed genetic score is
xij
c ()for gene l and xij
c ()for common variant vj. Note that
for the weighted sum collapsing method, xij
c ()= 0 for all
the common variants because common and rare variants
are collapsed into one single term. Let G =( g1, g2, …, gL)
denote the set of all the genes and CV =( v1, v2, …, vM)
denote the set of all common variants. If Yi is the disease
status or the trait value of individual i,t h e nt h em u l t i p l e
regression model is:
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where Ei is the vector of the environmental variables
for individual i, bE is the vector of coefficients for these
variables, g(·) is the link function, and μi is the mean of
Yi. For binary disease status we use the logit link func-
tion, and for the other three quantitative trait models
we use the identity link function. For parameter estima-
tion, we use a least absolute shrinkage and selection
operator (LASSO) [16], which penalizes the likelihood
function by adding the sum of the absolute value of the
coefficients (L1 penalty function). Many of the coeffi-
cients will be shrunk to 0 as a result of the property of
the L1 penalty function.
Comparing collapsing methods
The Genetic Analysis Workshop 17 (GAW17) data con-
tain 200 simulations, and we treat them as replicates.
We use each of the replicates to fit the regression
model using a LASSO. Genes with nonzero estimated
coefficients are taken to be identified. The consistency
of the identified genes across replicates by each method
is measured in the following way. Suppose that in the
fitted model for replicate i, sij =1i fg e n ej has a non-
zero coefficient and 0 otherwise. Then the consistency
of the method across different replicates is measured by:
C
F
ss ij ij
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12
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where F contains all the genes identified by the model
fitted in at least one replicate data set and |F| is the size
of F. The three collapsing methods are compared based
on this consistency score. The ability of the consistency
score to evaluate the performance of the collapsing
methods is debatable because a method can be consis-
tently bad but have a good consistency score. Therefore
we further compare the three collapsing methods using
the cross-validation error rate of the fitted model. We
fit one model for each of the 200 replicates and use the
fitted model to predict the trait values in the other 199
replicates. The prediction is then compared with the
true values to calculate the error rate. For the disease
trait, an area under curve (AUC) score is calculated for
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AUC score is returned, whereas for quantitative traits
the mean-square error is used as the measure of predic-
tion error.
Incorporating functional annotation
Mutations in the coding region that change the function of
the encoded proteins or that fall into highly conserved
regions tend to affect the biological function significantly.
For each SNP in the data, the functional annotation
describes whether the SNP is nonsynonymous or synon-
ymous. We try to incorporate this functional annotation
information by collapsing the nonsynonymous and synon-
ymous SNPs separately and shrinking their parameters to
different extents to allow different probabilities of associa-
tion. The modified model can be formulated as:
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where bl
nr () and bl
sr ()are the parameters for the col-
lapsed nonsynonymous and synonymous rare variants in
gene gl, respectively. To shrink the parameters for the
synonymous and nonsynonymous variants to different
extents, the penalized log-likelihood function is set as:
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where l(b) is the log-likelihood function, aj = ns indi-
cates that the corresponding variant is nonsynonymous,
and aj = s indicates that the variant is synonymous. The
two penalty parameters lns and ls are chosen based on the
cross-validation error rate within each replicate data set.
Results
Comparison of collapsing methods
Two hundred simulations in the GAW17 data set [17]
provide values of four traits, including disease, Q1, Q2,
and Q4. We treat these 200 simulations as replicates.
For each replicate, we fit a multiple regression model
using a LASSO. We measure the consistency of the sig-
nificant features across the 200 replicates by using the
score defined in Eq. (2); the comparison of the consis-
tency between the three collapsing methods is shown in
Table 1. For the disease model, the proportion collap-
sing method achieves the most consistent results across
replicates. For the other three traits, the proportion col-
lapsing method also has the best consistency.
Alternatively, we fit one model for each replicate and
use the fitted model to predict the trait values of the
other 199 replicates. The improvement in the prediction
accuracy resulting from the genetic features is thus
obtained and is shown in Table 2. The comparisons
show that the proportion collapsing method again has
the best prediction accuracy for all traits except Q4. In
fact, the prediction accuracy for Q4 decreases if the
genetic features are included; this is due to the structure
of the simulation model. Although Q4 has a heritability
of 0.7, none of the heritability is due to genes in the
data set. Based on the comparisons, we conclude that
the proportion collapsing method achieves the most
consistent results and the lowest prediction errors.
In addition, we rank genes and variants based on the
number of replicates that provide nonzero parameter
estimates for them. For a given threshold, the set of sig-
nificant genes or variants can be defined. By comparing
this list of genes with the true causal variants and genes
for disease, Q1, and Q2, we calculate the sensitivity and
specificity to draw the receiver operating characteristic
(ROC) curves, which are shown in Figure 1. Note that
sensitivity and specificity reflect the type I and II error of
the method, respectively. The area under the ROC
curves, defined as the AUC score, is also calculated for
each method. The higher the AUC score is, the better
performance the method has. Comparison of the ROC
curves and AUC scores for different methods shows that
for Q2 and disease, the data-adaptive collapsing method
performs better than the other two methods. For Q1,
however, the proportion collapsing method has the best
performance.
Identifying associated variants by incorporating
functional annotations
Intuitively, mutations in a gene that change the function of
the corresponding encoded protein tend to be more dele-
t e r i o u s .T h e r e f o r ew ec o l l a p s et h en o n s y n o n y m o u sa n d
synonymous rare variants into two different terms and
allow different shrinkage for them in the LASSO model.
We use the proportion collapsing method to do the col-
lapsing because of its consistently good performance for
most of the criteria and trait models. Results before and
after incorporating the functional annotation information
are compared with the list of truly associated SNPs to gen-
erate the ROC curves and their AUC scores, which are
shown in Figure 2. The AUC score increases the most for
Q2, from 0.51 to 0.67. For disease and Q1, the improve-
ments are 0.01 and 0.02, respectively. The improvements
in the AUC scores suggest that incorporating functional
Table 1 Consistency scores of the selected features from
the 200 replicates using the three different collapsing
methods
Method Q1 Q2 Q4 Disease
Proportion collapsing 475.7897 316.2296 291.7924 344.5995
Data-adaptive sum 645.315 649.8706 420.0192 369.6984
Weighted sum 803.3252 366.4013 323.6185 468.9865
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ciated variants. This is consistent with the fact that in
the simulation model all functional variants are
nonsynonymous.
I nT a b l e3 ,w es h o wt h e1 0m o s ts i g n i f i c a n tf e a t u r e s
associated with the four traits. According to the table,
there seem to be no environmental effects for Q2,
whereas Q4 seems to be affected mostly by the Age,
Sex, and Smoke covariates. The population information
is included as one of the covariates. But as shown in
Table 3, none of the traits rank the population variable
as the top 10 most significant feature. All traits except
Q4 seem to be significantly associated with variants
inside some genes. Compared with the list of true causal
variants and genes in the answer sheet, the LASSO
regression model detects both true causal common and
rare variants for Q1 and Q2 but not for disease. This is
because the disease liability is decided by the three
quantitative traits and a set of variants. However, in the
generalized linear model, none of the quantitative traits
are included as predictors, reducing the performance of
the model significantly, especially when these traits are
actually also decided by the variants included in the
model.
Discussion and conclusions
We compared three different collapsing methods using
the GAW17 data and explored one way to incorporate
the functional annotation information. The analysis
shows that for the GAW17 data, the proportion collap-
sing method tends to have the best performance in
terms of consistency across different simulations and
cross-validation error rate. Furthermore, incorporation
of the functional information leads to higher specificity
and sensitivity levels. Finally, by comparing the identi-
fied genes with the true causal genes, we show that the
LASSO method in combination with the rare-variants
collapsing method is able to detect most of the true cau-
sal variants and genes for the three quantitative traits.
However, several issues need to be addressed with
regard to the analysis. First, note that, based on both the
consistency score and the cross-validation error rate, the
performance of the proportion collapsing method drops
when applied to Q2 and disease trait compared to Q1. In
fact, Q1 is affected by the covariates Age and Smoke,
which can be consistently detected easily and which
cause the consistency score to be the best. For disease
and Q2, this effect of the covariates is much weaker and
thus leads to worse consistency. These results suggest
that the consistency score may not be optimal to evaluate
the performance of the collapsing methods.
Second, the improvement in the AUC score achieved by
incorporating the functional annotation was not impress-
i v ef o rd i s e a s ea n dQ 1 ,g i v e nthat all the functional var-
iants in the simulation model are nonsynonymous. This
again can be related to the higher residual heritability of
Table 2 Improvement in the prediction accuracy of the fitted regression model in the testing replicates using the
three collapsing methods
Method Q1 (mean-square error) Q2 (mean-square error) Q4 (mean-square error) Disease (average AUC score)
Proportion collapsing 0.1226466 0.0116719 −0.0068168 0.0023503
Data-adaptive sum 0.1193559 0.0027142 −0.0080903 0.0015294
Weighted sum 0.0779981 0.0080481 −0.0060441 0.0013407
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Figure 1 ROC curves and AUC scores of different collapsing methods on Q1, Q2, and disease models. PROP, proportion collapsing
method; DAS, data-adaptive sum method; and WS, weighted-sum method. AUC scores are shown next to the names of the corresponding
methods.
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also suggests that our current way of incorporating the
functional annotation is not optimal.
Third, many important questions are not answered in
this analysis. They include how to detect the interac-
tions between genes and environmental variables, alter-
native ways to incorporate the functional annotation
such as Bayesian methods with different prior probabil-
ities for the synonymous and nonsynonymous variants,
adding the quantitative traits in the disease models as
predictors, and applying the generalized additive model.
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